Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypertonic Sodium Lactate in Pediatric Dengue Shock Syndrome
NCT00966628Phase 3Unknown
- Sponsor
- Innogene Kalbiotech
- Start
- May 2008
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hypertonic sodium lactate in dengue shock syndrome (DSS), sponsored by Innogene Kalbiotech. Status: unknown.
02
Drugs
hypertonic sodium lactate
03
Conditions
dengue shock syndrome (DSS)
Beyond the preview
Go deeper on NCT00966628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00966628.